These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34736896)

  • 1. β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins.
    Ninkina N; Millership SJ; Peters OM; Connor-Robson N; Chaprov K; Kopylov AT; Montoya A; Kramer H; Withers DJ; Buchman VL
    J Biol Chem; 2021 Dec; 297(6):101375. PubMed ID: 34736896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
    Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
    J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons.
    Goloborshcheva VV; Kucheryanu VG; Voronina NA; Teterina EV; Ustyugov AA; Morozov SG
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
    Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
    J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
    Schlüter OM; Fornai F; Alessandrí MG; Takamori S; Geppert M; Jahn R; Südhof TC
    Neuroscience; 2003; 118(4):985-1002. PubMed ID: 12732244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
    Dong Z; Ferger B; Feldon J; Büeler H
    J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.
    German DC; Liang CL; Manaye KF; Lane K; Sonsalla PK
    Neuroscience; 2000; 101(4):1063-9. PubMed ID: 11113355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activation.
    Thomas B; Mandir AS; West N; Liu Y; Andrabi SA; Stirling W; Dawson VL; Dawson TM; Lee MK
    PLoS One; 2011 Jan; 6(1):e16706. PubMed ID: 21304957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual role for α-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo.
    Somayaji M; Cataldi S; Choi SJ; Edwards RH; Mosharov EV; Sulzer D
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32701-32710. PubMed ID: 33273122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.
    Chandra S; Fornai F; Kwon HB; Yazdani U; Atasoy D; Liu X; Hammer RE; Battaglia G; German DC; Castillo PE; Südhof TC
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14966-71. PubMed ID: 15465911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity.
    Bucher ML; Dunn AR; Bradner JM; Egerton KS; Burkett JP; Johnson MA; Miller GW
    Eur J Neurosci; 2024 May; 59(10):2483-2501. PubMed ID: 38532289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.
    Lotharius J; Brundin P
    Hum Mol Genet; 2002 Oct; 11(20):2395-407. PubMed ID: 12351575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl-4-phenylpyridinium (MPP+) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons.
    Martí Y; Matthaeus F; Lau T; Schloss P
    Mol Cell Neurosci; 2017 Sep; 83():37-45. PubMed ID: 28673772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family.
    Anwar S; Peters O; Millership S; Ninkina N; Doig N; Connor-Robson N; Threlfell S; Kooner G; Deacon RM; Bannerman DM; Bolam JP; Chandra SS; Cragg SJ; Wade-Martins R; Buchman VL
    J Neurosci; 2011 May; 31(20):7264-74. PubMed ID: 21593311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins.
    Carnazza KE; Komer LE; Xie YX; Pineda A; Briano JA; Gao V; Na Y; Ramlall T; Buchman VL; Eliezer D; Sharma M; Burré J
    Cell Rep; 2022 Apr; 39(2):110675. PubMed ID: 35417693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
    J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.